TEAM
Jordi Martorell
CEO and Co-Founder
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
Noemí Balà
CTO and Co-Founder
PhD Candidate in Chemical Engineering. Noemí has been working on this project since 2016, she has designed and executed biomaterial and bioadhesive synthesis, mechanical testing, plasma technology for protein attachment and cell culture techniques for tissue regeneration.
PhD Candidate in Chemical Engineering. Noemí has been working on this project since 2016, she has designed and executed biomaterial and bioadhesive synthesis, mechanical testing, plasma technology for protein attachment and cell culture techniques for tissue regeneration.
PhD Candidate in Chemical Engineering. Noemí has been working on this project since 2016, she has designed and executed biomaterial and bioadhesive synthesis, mechanical testing, plasma technology for protein attachment and cell culture techniques for tissue regeneration.
Salvador Borrós
CSO and Co-Founder
PhD in Analytical Chemistry Materials. He is the Chief of the Chemical Engineering and Material Sciences Department and of the Bioengineering Department at the IQS School of Engineering. He is also the Head of the Materials Engineering Group (GEVAB). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
PhD in Analytical Chemistry Materials. He is the Chief of the Chemical Engineering and Material Sciences Department and of the Bioengineering Department at the IQS School of Engineering. He is also the Head of the Materials Engineering Group (GEVAB). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
PhD in Analytical Chemistry Materials. He is the Chief of the Chemical Engineering and Material Sciences Department and of the Bioengineering Department at the IQS School of Engineering. He is also the Head of the Materials Engineering Group (GEVAB). Dr. Borrós is Professor of Material Sciences since 1994. His research on industrial polymers pivoted in 2005 to intelligent biomaterials. His portfolio of human applications includes tissue regeneration, nanoparticles or synthetic vectors for drug or gene delivery.
Vicenç Riambau
Medical Liaison and Co-Founder
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. He is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. He is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. He is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
Advisory Board
Elazer Edelman
Medical Advisor
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
Rosendo Garganta
Business Advisor
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and He collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and He collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and He collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
Mercedes Balcells
Scientific Advisor
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
Adam Groothuis
Business Advisor
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical devices companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical devices companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical devices companies.
The ultimate solution for aortic diseases
The ultimate solution for aortic diseases
The ultimate solution for aortic diseases
© 2019. AORTYX.